Ceftibuten
Ceftibuten is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age
P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants
Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function
Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants
Clinical Trials (8)
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age
P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants
Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function
Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants
To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy Adults
PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment
Short-term Antibiotic Therapy for Pyelonephritis in Childhood
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8